{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-26-125196","form_type":"8-K","ticker":"PRPO","cik":"0001043961","company_name":"Precipio, Inc.","filed_at":"2026-11-10T21:15:38+00:00","discovered_at":"2026-11-10T21:17:00.251075+00:00","generated_at":"2026-11-10T21:17:27.900692+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Precipio Q3-2026 revenue $7.3M, up 8% YoY to a record; Adjusted EBITDA $0.4M, operating cash flow $0.6M","bullets":["Revenue $7.3M, up 8% YoY from $6.8M in Q3-2025 and above $7.0M in Q2-2026; product revenue $1.0M (+40% YoY), pathology revenue $6.3M (+5% YoY).","Adjusted EBITDA $0.4M vs $0.5M in Q3-2025 and $0.4M in Q2-2026; GAAP net income was roughly $0.0M versus a $0.1M net loss a year earlier.","Cash flow from operations $0.6M; total cash rose $0.5M to over $3.5M at September 30, 2026, versus $2.3M in Q3-2025.","CEO Ilan Danieli said pathology provides the financial foundation for growth and serves as the clinical validation platform for proprietary diagnostic products.","Management hosted a shareholder call at 5 PM ET on November 10, 2026; full results are in the Form 10-Q filed the same day."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-125196","json":"https://secwatch.observer/filing/0001104659-26-125196.json","markdown":"https://secwatch.observer/filing/0001104659-26-125196.md","text":"https://secwatch.observer/filing/0001104659-26-125196.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1043961/000110465926125196/0001104659-26-125196-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1043961/000110465926125196/tm2629335d1_8k.htm"},"model":{"generated_by":"deepseek-v4.1-flash:cloud@v2","generated_at":"2026-11-10T21:17:27.900692+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}